ARTICLE | Clinical News
Monoclonal antibodies against PSMA regulatory update
August 28, 2000 7:00 AM UTC
Cornell University received U.S. patent No. 6,107,090 covering the use of monoclonal antibodies that bind to the extracellular domain of prostate-specific membrane antigen (PSMA), to treat or diagnos...